ClinicalTrials.gov
ClinicalTrials.gov Menu

Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01412671
Recruitment Status : Completed
First Posted : August 9, 2011
Last Update Posted : April 12, 2012
Sponsor:
Information provided by:
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2011
  Actual Study Completion Date : September 2011